Saccade
New accelerator entry · 2026-10-06 · the record
MentionFox
Alzheimer's testing today is bottlenecked around the onset of symptoms, when the damage is already done. Current treatments, including the FDA-approved drugs released in 2024, don't reverse the disease; they only slow it down.
Sell to companies like these? Paste your website and see 10 with a filed reason to buy this month. Free.
Opens in a new tab. No signup.
New accelerator entry · 2026-10-06 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Saccade.
Free to see. No signup.
We'll show it in your MentionFox inbox when Saccade raises, hires or launches. No email unless you switch it on.
Watch Saccade →Get the full cited report on Saccade
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Saccade: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
Alzheimer's testing today is bottlenecked around the onset of symptoms, when the damage is already done. Current treatments, including the FDA-approved drugs released in 2024, don't reverse the disease; they only slow it down. Earlier detection means earlier intervention. Eye movement changes linked to Alzheimer's surface sooner than any other biomarker, up to 15 years before symptoms appear. We deliver a 15-minute VR assessment delivered to patients in longevity clinics: • Tasks: patients perform visual tasks designed by neurologists to trigger a distinct oculomotor response in people with Alzheimer's or on its path • Hardware: our patent-pending attachment connects to any VR headset on the market and captures these eye movement patterns. • Analysis: the patterns are compared against our ML model to produce a risk analysis. Once classified, patients can access new interventions, such as the FDA-approved drugs. They're also referred to longevity practices, neurology practices or both, depending on their stage of decline. Testing for the earliest biomarkers allows the earliest possible intervention. In some cases, that slows the disease enough that patients outlive the onset of symptoms and never face memory loss in their lifetime.
Checked away from the directory entry. Neither line below comes from the company's Y Combinator page.
Clinician-led eye-movement assessment. Explore the visual tasks, research measurements and what to expect at your visit.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Counted only where a thread links to this company's own site, announces it by name on that forum, or names it beside its own Y Combinator batch. A thread whose title merely carries the words is not counted — a name is not an identifier. Hacker News is not us, and nothing above is our opinion of the company.
Founders, titles and bios as the company published them. Photographs are our own copies of the ones on that record, so they do not break when the original link expires.
No investor is drawn from a Form D — the form states how many invested and never who. The one investor on this graph is named because a batch has exactly one.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Saccade: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Saccade covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist SaccadeYou get an alert in MentionFox the next time this company shows up.
If you're behind Saccade: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
Sourced from the company's Y Combinator directory entry, from the company's own site, read directly on 2026-10-06 (saccade.health), and from Hacker News, where 1 thread met the matching rule stated beside the count.
Each opens in a new tab, filled in for Saccade. With no account yet, you sign up free and land on the result.

https://mentionfox.com/funding/yc-saccade